Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is a once-weekly subcutaneous injection, not a drink — but the question of when to take it matters more than people expect. The short answer: any consistent day of the week works, and the time of day is up to you, as long as you stick to it. Here is what the clinical evidence and the medicine's approved guidance actually say about timing, routine, and getting the most from your treatment. Because Mounjaro is a prescription-only medicine requiring clinical assessment, your prescriber will confirm the schedule that suits your specific circumstances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first practical step is choosing a day of the week you can reliably protect. Many people pick a weekend morning: there is less rush, you are more likely to be at home, and the pen is in the fridge rather than wherever your bag happens to end up. Others prefer a Monday because it anchors the week. Neither is clinically better. What the NHS tirzepatide guidance makes clear is that the day itself is your choice, provided each dose is separated from the last by a full seven days.
If you ever need to shift the day (say, a planned holiday clashes with your usual injection day) you can move it forward or back by a couple of days, as long as the gap between doses is at least three days. Do not do this routinely; it is a one-off adjustment, not a flexible schedule. Your prescriber or our aftercare team can advise if you are unsure.
One quick habit worth building: before you inject, check the pen's expiry date and that the solution looks clear. Takes about thirty seconds and means you are never caught out.
Unlike the oral weight-loss tablet (which requires an empty stomach and a 30-minute wait before food or coffee), tirzepatide injections have no meal-timing rule. You can inject in the morning with breakfast, in the evening after dinner, or at any point in between. The medicine is delivered directly under the skin and absorbed independently of what is in your stomach.
That said, some people find that injecting in the evening means any early nausea (most common in the first couple of weeks at a new dose) passes during sleep rather than during their working day. Others prefer morning so the dose is ticked off before the day gets away from them. Both approaches are reasonable; the right one is whichever you will actually maintain week after week.
If you are wondering about alcohol specifically, the relationship between Mounjaro and alcohol is worth reading separately, there are a few practical points that are distinct from the timing question. For instance, if you want to know whether you can drink on Mounjaro in general, or have a specific question about whether it is safe to drink on Mounjaro at all, we cover both in detail elsewhere on the site, and it is worth a look before your next social occasion. You can also find guidance on drinking while taking Mounjaro if you want a more treatment-focused perspective on the same topic.
A missed dose handled correctly is far less disruptive than people fear. If you remember within four days of your usual injection day, take the dose as soon as you remember and then resume your normal weekly schedule from there. If more than four days have passed, skip that dose entirely and continue with the next one on your regular day.
Never take two doses close together to compensate. The tirzepatide patient information leaflet covers missed doses in detail; for anything beyond that straightforward scenario (if you are ill, recently had surgery, or are changing dose) contact a prescriber directly rather than working it out alone. Our aftercare team is available seven days a week for exactly these situations.
Dose changes and titration follow a schedule set by your prescriber, not by how hungry (or not) you feel. Treatment typically starts at 2.5 mg for the first four weeks, with the prescriber reviewing progress before moving up. The starter dose is there to let your body adjust; it is not the dose that drives the weight-loss results seen in clinical trials.
Timing is one part of safe use; context is the other. Mounjaro is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. Women using oral contraceptives should add a barrier method for the first four weeks of treatment and for four weeks after any dose increase, because tirzepatide can reduce how much of the pill is absorbed, a point backed by NHS England's guidance on weight-management injections. Transdermal options (patches or gels) avoid this concern entirely and are worth discussing with your GP or prescriber if relevant.
If you are on other regular medicines, tell your prescriber before starting. The slowing of gastric emptying that Mounjaro produces can shift the absorption timing of other oral drugs, which is occasionally clinically significant. It is the kind of detail that a same-day clinical review by a real prescriber (not a questionnaire algorithm) is designed to catch. You can read more about what our clinical approach involves if you want to understand how that review works in practice.
For a broader look at what tirzepatide treatment involves, including how private treatment is priced and what is included, the weight-loss treatment overview sets out the full picture. When you are ready to talk through whether it is right for you, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.